Cargando…
Acetate: Friend or foe against breast tumour growth in the context of obesity?
Acetate is reported as a regulator of fat mass but also as lipogenic source for cancer cells. Breast cancer is surrounded by adipose tissue and has been associated with obesity. However, whether acetate contributes to cancer cell metabolism as lipogenic substrate and/or by changing fat storage and e...
Autores principales: | Yelek, Caner, Mignion, Lionel, Joudiou, Nicolas, Terrasi, Romano, Gourgue, Florian, Van Hul, Matthias, Delzenne, Nathalie, Gallez, Bernard, Corbet, Cyril, Muccioli, Giulio G., Feron, Olivier, Cani, Patrice D., Jordan, Bénédicte F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753876/ https://www.ncbi.nlm.nih.gov/pubmed/33107196 http://dx.doi.org/10.1111/jcmm.16034 |
Ejemplares similares
-
Tumor Metabolism Is Affected by Obesity in Preclinical Models of Triple-Negative Breast Cancer
por: Yelek, Caner, et al.
Publicado: (2022) -
Obesity and triple‐negative‐breast‐cancer: Is apelin a new key target?
por: Gourgue, Florian, et al.
Publicado: (2020) -
Impact of Inhibition of the Mitochondrial Pyruvate Carrier on the Tumor Extracellular pH as Measured by CEST-MRI
por: Buyse, Chloé, et al.
Publicado: (2021) -
Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification
por: Buyse, Chloe, et al.
Publicado: (2022) -
Metabolic imaging using hyperpolarized (13)C‐pyruvate to assess sensitivity to the B‐Raf inhibitor vemurafenib in melanoma cells and xenografts
por: Acciardo, Stefania, et al.
Publicado: (2019)